Acorai, headquartered in Skane, Sweden, has developed The Acorai Heart Monitor, a non-invasive intracardiac pressure monitoring system that detects impending heart failure earlier and is cheaper than any other tool on the market. The device offers a heart monitor that helps healthcare professionals stabilize their patients sooner, enabling healthcare personnel to adjust medication proactively and reduce both heart failure re-hospitalization and mortality rates. The Acorai Heart Monitor uses machine learning analysis of pressure dynamics in acoustics, vibratory and waveform data to monitor intracardiac pressures non-invasively. This technology has a low-risk clinical and regulatory pathway, a low dependence on reimbursement, and a fast track to commercialization.